The US Food and Drug Administration (FDA) released a draft guidance on April 3 providing recommendations to sponsors and testing sites on data integrity for bioavailability and bioequivalence (BA/BE) ...

Given data integrity issues that have been uncovered in the past, in April 2024, the U.S. Food and Drug Administration (FDA) published a draft guidance to applicants and testing site management on ...

In a recent Hayes Management Consulting blog, Leala M. Williams explains if Biometric identification is the answer to patient data integrity issues. Long gone are the days of standalone demographic ...

Duplicates of crystal structures are flooding databases, implicating repositories hosting organic, inorganic, and ...

In the age of advanced data analytics and artificial intelligence (AI), organizations are continuously confronted with new and increasingly complex challenges of data legitimacy. The proliferation of ...

A new research report from Yale School of Medicine offers an up-close look at how biased artificial intelligence can affect clinical outcomes. The study focuses specifically on the different stages of ...

Data integrity is the fulcrum of pharma operations. All departments in a pharmaceutical company depend on reliable and valid results reported by its quality control laboratory. The inaccurate results ...

Australian organisations have lost an average of A$493,000 over the past 12 months due to data integrity flaws, hampering their artificial intelligence (AI) ambitions and eroding their competitive ...

Sharon Regional Health System faced a dilemma after completing a comprehensive master patient index cleanup in preparation for its new electronic health record system. While the cleanup had eliminated ...

There are wide discrepancies in data quality for hotel transactions across global regions, with the largest occurring in Asia-Pacific. Because hotels and agencies need to harness data quality to ...